Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia.

Saved in:
Bibliographic Details
Title: Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia.
Authors: Braga L; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Ali H; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Secco I; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Chiavacci E; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Neves G; MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Goldhill D; Department of Infectious Diseases, Imperial College London, London, UK., Penn R; Department of Infectious Diseases, Imperial College London, London, UK., Jimenez-Guardeño JM; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK., Ortega-Prieto AM; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK., Bussani R; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Cannatà A; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Rizzari G; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Collesi C; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.; International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Schneider E; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK.; International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy., Arosio D; Istituto di Biofisica (IBF), Consiglio Nazionale delle Ricerche (CNR), Trento, Italy., Shah AM; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK., Barclay WS; Department of Infectious Diseases, Imperial College London, London, UK., Malim MH; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK., Burrone J; MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Giacca M; King's College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK. mauro.giacca@kcl.ac.uk.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. mauro.giacca@kcl.ac.uk.; International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy. mauro.giacca@kcl.ac.uk.
Source: Nature [Nature] 2021 Jun; Vol. 594 (7861), pp. 88-93. Date of Electronic Publication: 2021 Apr 07.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4687
DOI:10.1038/s41586-021-03491-6